Your browser doesn't support javascript.
loading
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts.
Moskowitz, Chaya S; Ronckers, Cécile M; Chou, Joanne F; Smith, Susan A; Friedman, Danielle Novetsky; Barnea, Dana; Kok, Judith L; de Vries, Simone; Wolden, Suzanne L; Henderson, Tara O; van der Pal, Helena J H; Kremer, Leontien C M; Neglia, Joseph P; Turcotte, Lucie M; Howell, Rebecca M; Arnold, Michael A; Schaapveld, Michael; Aleman, Berthe; Janus, Cecile; Versluys, Birgitta; Leisenring, Wendy; Sklar, Charles A; Begg, Colin B; Pike, Malcolm C; Armstrong, Gregory T; Robison, Leslie L; van Leeuwen, Flora E; Oeffinger, Kevin C.
Affiliation
  • Moskowitz CS; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Chou JF; Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
  • Smith SA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Friedman DN; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Barnea D; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kok JL; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • de Vries S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Wolden SL; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Henderson TO; Memorial Sloan Kettering Cancer Center, New York, NY.
  • van der Pal HJH; University of Chicago Medicine Comer Children's Hospital, Chicago, IL.
  • Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Neglia JP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Turcotte LM; University of Minnesota Masonic Cancer Center, Minneapolis, MN.
  • Howell RM; University of Minnesota Masonic Cancer Center, Minneapolis, MN.
  • Arnold MA; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Schaapveld M; Nationwide Children's Hospital, Columbus, OH.
  • Aleman B; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Janus C; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Versluys B; Erasmus University, Rotterdam, the Netherlands.
  • Leisenring W; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Sklar CA; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Begg CB; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Pike MC; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Armstrong GT; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Robison LL; St Jude Children's Research Hospital, Memphis, TN.
  • van Leeuwen FE; St Jude Children's Research Hospital, Memphis, TN.
  • Oeffinger KC; Netherlands Cancer Institute, Amsterdam, the Netherlands.
J Clin Oncol ; 39(27): 3012-3021, 2021 09 20.
Article in En | MEDLINE | ID: mdl-34048292
ABSTRACT

PURPOSE:

Women treated with chest radiation for childhood cancer have one of the highest risks of breast cancer. Models producing personalized breast cancer risk estimates applicable to this population do not exist. We sought to develop and validate a breast cancer risk prediction model for childhood cancer survivors treated with chest radiation incorporating treatment-related factors, family history, and reproductive factors.

METHODS:

Analyses were based on multinational cohorts of female 5-year survivors of cancer diagnosed younger than age 21 years and treated with chest radiation. Model derivation was based on 1,120 participants in the Childhood Cancer Survivor Study diagnosed between 1970 and 1986, with median attained age 42 years (range 20-64) and 242 with breast cancer. Model validation included 1,027 participants from three cohorts, with median age 32 years (range 20-66) and 105 with breast cancer.

RESULTS:

The model included current age, chest radiation field, whether chest radiation was delivered within 1 year of menarche, anthracycline exposure, age at menopause, and history of a first-degree relative with breast cancer. Ten-year risk estimates ranged from 2% to 23% for 30-year-old women (area under the curve, 0.63; 95% CI, 0.50 to 0.73) and from 5% to 34% for 40-year-old women (area under the curve, 0.67; 95% CI, 0.54 to 0.84). The highest risks were among premenopausal women older than age 40 years treated with mantle field radiation within a year of menarche who had a first-degree relative with breast cancer. It showed good calibration with an expected-to-observed ratio of the number of breast cancers of 0.92 (95% CI, 0.74 to 1.16).

CONCLUSION:

Breast cancer risk varies among childhood cancer survivors treated with chest radiation. Accurate risk prediction may aid in refining surveillance, counseling, and preventive strategies in this population.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoplasms, Radiation-Induced Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoplasms, Radiation-Induced Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2021 Document type: Article